[1] Smolarczyk R, Cichon T, Jarosz M, Szala S. HMGB1--its role in tumor progression and anticancer therapy [J]. Postepy Hig Med Dosw (Online), 2012, 66(3)∶913-920 [2] Wild CA, Brandau S, Lotfi R, et al. HMGB1 is overexpressed in tumor cells and promotes activity of regulatory T cells in patients with head and neck cancer [J]. Oral Oncol, 2012, 48(2)∶409-416 [3] Zhang CL, Shu MG, Qi HW, Li LW. Inhibition of tumor angiogenesis by HMGB1 A box peptide [J]. Med Hypotheses, 2008, 70(1)∶343-345 [4] Tang Q, Li J, Zhu H, et al. Hmgb1-IL-23-IL-17-IL-6-Stat3 axis promotes tumor growth in murine models of melanoma [J]. Mediators Inflamm, 2013, 2013∶713859 [5] Zhang W, Tian J, Hao Q. HMGB1 combining with tumor-associated macrophages enhanced lymphangiogenesis in human epithelial ovarian cancer [J]. Tumour Biol, 2014, 35∶2175-2186 [6] Aguilar-Cazares D, Meneses-Flores M, Prado-Garcia H, et al. Relationship of dendritic cell density, HMGB1 expression, and tumor-infiltrating lymphocytes in non-small cell lung carcinomas [J]. Appl Immunohistochem Mol Morphol, 2014, 22(1)∶105-13 [7] 刘勇,邱元正,张欣,等.HMGB1与VEGF蛋白在喉鳞状细胞癌中的表达及其相关性研究[J].临床耳鼻咽喉头颈外科杂志,2011,29(6)∶265-269 [8] Kang R, Tang D, Schapiro NE, et al. The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics [J]. Oncogene, 2014, 33(3)∶567-577 [9] Yang Y, Huang JQ, Zhang X, Shen LF. MiR-129-2 functions as a tumor suppressor in glioma cells by targeting HMGB1 and is down-regulated by DNA methylation [J]. Mol Cell Biochem, 2015, 404(1)∶229-239 [10] Zhang Z, Wang M, Zhou L, et al. Increased HMGB1 and cleaved caspase-3 stimulate the proliferation of tumor cells and are correlated with the poor prognosis in colorectal cancer [J]. J Exp Clin Cancer Res, 2015, 34(1)∶51-56 [11] Liu Z, Falo LD, Jr., You Z. Knockdown of HMGB1 in tumor cells attenuates their ability to induce regulatory T cells and uncovers naturally acquired CD8 T cell-dependent antitumor immunity [J]. J Immunol, 2011, 187(1)∶118-125 [12] Tang D, Lotze MT. Tumor immunity times out: TIM-3 and HMGB1 [J]. Nat Immunol, 2012, 13(4)∶808-810 |